此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

AUB-MC 的多学科减肥计划

2026年11月3日 更新者:Marlene Chakhtoura、American University of Beirut Medical Center

AUB-MC 的多学科减肥计划:开放标签试点随机对照试验

The current project aims at evaluating the feasibility and efficacy of a multi-disciplinary weight loss program, using an innovative and simple dietary intervention at the American University of Beirut Medical Center (AUB-MC). Such intervention is expected to enhance patients' compliance and adherence to lifestyle changes. In addition, the program includes supervised exercise sessions and behavioral therapy. Therefore, our project proposes an evidence based approach to close the obesity treatment gaps.

研究概览

研究类型

介入性

注册 (估计的)

20

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Riad El Solh
      • Beirut、Riad El Solh、黎巴嫩、1107 2020
        • American University of Beirut - Medical Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Lebanese adult with obesity (≥18 years), obesity being defined as BMI ≥ 30 kg/m2
  • Patients who can commit to frequent visit trials as per study protocol
  • Patients not traveling outside Lebanon for at least the 6-month period of the trial
  • Patients tolerating Metformin after a run-in period of 2 weeks

Exclusion Criteria:

  • Patients who have taken other weight reducing drug therapy in the previous 6 months
  • Patients who have undergone bariatric therapy or endoscopic procedure, or planning to do so in the near future (at < 6 months)
  • Patients with diabetes
  • Patients working at AUB-MC, as we will not be able to assess the adherence to study visits nor the feasibility of such a program in the general population, presenting to AUB-MC only for clinical care
  • A family member of a patient already enrolled in the study, as the participants will not be independent
  • Pregnant obese patients
  • Patients with pacemakers
  • Patients known to have hypertension, cardiac, pulmonary, renal or liver disease, active cancer or psychiatric illnesses
  • History of any surgery of less than 6 weeks duration
  • Patients known to have disabling osteoarthritic or orthopedic problems
  • Patients secondary uncontrolled endocrine disorders (thyroid disorders, polycystic ovary, Cushing disease), or drug induced obesity (such as anti-psychotic, steroids, hormonal therapy).

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Multidisciplinary program

Multidisciplinary weight loss program

Diet and behavioral therapy,and supervised exercise sessions

1 tablet, twice daily

其他:Control

Standard care

1 tablet, twice daily

General lifestyle tips

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Mean percent weight loss per treatment arm
大体时间:6 months after enrollment

[(baseline weight-follow up weight at 6 months)/ baseline weight] X 100

6 months after enrollment

其他结果措施

结果测量
措施说明
大体时间
Change in weight
大体时间:6 months after enrollment

TANITA Body Composition (BC) 418 MA Segmental Body Composition Analyzer will measure Weight in kg

6 months after enrollment
Change in BMI
大体时间:6 months after enrollment

TANITA BC 418 MA Segmental Body Composition Analyzer will measure BMI (kg/m^2) by combining the height and weight.

6 months after enrollment
Change in body composition
大体时间:6 months after enrollment

TANITA BC 418 MA Segmental Body Composition Analyzer will measure total body measurements for: Fat Mass, Fat Free Mass, Total Body Water (in kg)

6 months after enrollment
basal metabolic rate (BMR)
大体时间:6 months after enrollment

TANITA BC 418 MA Segmental Body Composition Analyzer will measure BMR

6 months after enrollment
Change in physical fitness (distance)
大体时间:6 months after enrollment

Physical fitness will be assessed using the 6 minute walk test. Measure to be collected at beginning and end of test is: distance covered in meters

6 months after enrollment
Change in resting blood pressure before and after physical exercise
大体时间:6 months after enrollment

Physical fitness will be assessed using the 6 minute walk test. Measure to be collected at beginning and end of test is: resting blood pressure

6 months after enrollment
Change in oxygen saturation before and after physical exercise
大体时间:6 months after enrollment

Physical fitness will be assessed using the 6 minute walk test. Measure to be collected at beginning and end of test is: oxygen saturation

6 months after enrollment
Change in heart rate before and after physical exercise
大体时间:6 months after enrollment

Physical fitness will be assessed using the 6 minute walk test. Measure to be collected at beginning and end of test is: heart rate.

6 months after enrollment
Change in physical fitness (Perceived Exertion)
大体时间:6 months after enrollment

Physical fitness will be assessed using the 6 minute walk test. Rated Perceived Exertion (RPE) scale score will be administered.

6 months after enrollment
Change in levels of appetite hormones and metabolic markers
大体时间:6 months after enrollment

At visit 3 and completion visit (visit 5), blood samples will be withdrawn for various hormones and proteins related to appetite and satiety including Gastric inhibitory polypeptide (GIP), Leptin, Glucagon like peptide 1 (GLP1), Irisin, Insulin, Ghrelin, Orexin, IL6

These samples will be processed and preserved in the Calcium Metabolism and Osteoporosis Program lab in our institution, and the tests will be run later on, when additional funds are available.

6 months after enrollment
Change in levels of Mineral markers and hormones (cross laps)
大体时间:6 months after enrollment

At visit 3 and completion visit (visit 5), blood samples will be withdrawn for various mineral markers and hormones including Crosslaps (pg/mL).

These samples will be processed and preserved in the Calcium Metabolism and Osteoporosis Program lab in our institution, and the tests will be run later on, when additional funds are available.

6 months after enrollment
Change in levels of Mineral markers and hormones (Osteocalcin)
大体时间:6 months after enrollment

At visit 3 and completion visit (visit 5), blood samples will be withdrawn for various mineral markers and hormones including Osteocalcin (ng/mL).

These samples will be processed and preserved in the Calcium Metabolism and Osteoporosis Program lab in our institution, and the tests will be run later on, when additional funds are available.

6 months after enrollment
Participants' compliance
大体时间:6 months after enrollment

Adherence to the dietary intervention: [Number of days the dieticians are contacted/ Total number of days] X 100 Adherence to program visits: [Number of visits attended/ Total number of visits] X 100

6 months after enrollment

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年8月15日

初级完成 (估计的)

2027年9月15日

研究完成 (估计的)

2027年9月15日

研究注册日期

首次提交

2019年7月18日

首先提交符合 QC 标准的

2019年12月10日

首次发布 (实际的)

2019年12月11日

研究记录更新

最后更新发布 (实际的)

2026年11月5日

上次提交的符合 QC 标准的更新

2026年11月3日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅